News

Zacks Investment Research on MSN3h
Recursion Pharmaceuticals (RXRX) Surpasses Market Returns: Some Facts Worth Knowing
Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $5.72, moving +2.24% from the previous trading session. The stock's performance was ahead of the S&P 500's daily gain of 0.28%.
Microsoft replaces legacy JavaScript engine to improve security in Windows 11
Microsoft officially retired JScript years ago, along with proper support for the original Internet Explorer browser. However ...
Here's Why Shares in Recursion Pharmaceuticals Surged Today
Shares in biotech company Recursion Pharmaceuticals ( RXRX 12.07%) surged by more than 12% by 11 a.m. ET today. The move is ...
Fierce Biotech2d
Rallybio shifts gears, cashing out of Recursion pact to extend runway
Rallybio has swerved away from its Recursion Pharmaceuticals pact, accepting $7.5 million upfront for its share of a preclinical program to extend its cash runway to mid-2027.
Recursion to buy Rallybio’s ownership in jointly developed bone disorder drug
Rallybio (NASDAQ:RLYB) shares climbed ~114% in the premarket on Tuesday after the company announced an agreement to sell its ...